Lihua Ding

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Cetylpyridinium chloride inhibits hepatocellular carcinoma growth and metastasis through regulating epithelial-mesenchymal transition and apoptosis.

Cetylpyridinium chloride inhibits hepatocellular carcinoma growth and metastasis through regulating epithelial-mesenchymal transition and apoptosis.

Journal: PloS one

Published: June 10, 2024

PAIT effect: Padlock activator inhibits the trans-cleavage activity of CRISPR/Cas12a.

PAIT effect: Padlock activator inhibits the trans-cleavage activity of CRISPR/Cas12a.

Journal: Biosensors & bioelectronics

Published: April 23, 2024

Glutamine binds HSC70 to transduce signals inhibiting IFN-β-mediated immunogenic cell death.

Glutamine binds HSC70 to transduce signals inhibiting IFN-β-mediated immunogenic cell death.

Journal: Developmental cell

Published: March 03, 2024

HPIP is an essential scaffolding protein running through the EGFR-RAS-ERK pathway and drives tumorigenesis.

HPIP is an essential scaffolding protein running through the EGFR-RAS-ERK pathway and drives tumorigenesis.

Journal: Science advances

Published: June 09, 2023

MiR-3180 inhibits hepatocellular carcinoma growth and metastasis by targeting lipid synthesis and uptake.

MiR-3180 inhibits hepatocellular carcinoma growth and metastasis by targeting lipid synthesis and uptake.

Journal: Cancer cell international

Published: December 22, 2022

HUNK inhibits epithelial-mesenchymal transition of CRC via direct phosphorylation of GEF-H1 and activating RhoA/LIMK-1/CFL-1.

HUNK inhibits epithelial-mesenchymal transition of CRC via direct phosphorylation of GEF-H1 and activating RhoA/LIMK-1/CFL-1.

Journal: Cell death & disease

Published: September 29, 2022

SARS-CoV-2 spike L452R mutation increases Omicron variant fusogenicity and infectivity as well as host glycolysis.

SARS-CoV-2 spike L452R mutation increases Omicron variant fusogenicity and infectivity as well as host glycolysis.

Journal: Signal transduction and targeted therapy

Published: February 10, 2022

Transcriptional Repression of Aerobic Glycolysis by OVOL2 in Breast Cancer.

Transcriptional Repression of Aerobic Glycolysis by OVOL2 in Breast Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 06, 2022

MicroRNA-377-3p inhibits hepatocellular carcinoma growth and metastasis through negative regulation of CPT1C-mediated fatty acid oxidation.

MicroRNA-377-3p inhibits hepatocellular carcinoma growth and metastasis through negative regulation of CPT1C-mediated fatty acid oxidation.

Journal: Cancer & metabolism

Published: May 17, 2021

A novel chemical inhibitor suppresses breast cancer cell growth and metastasis through inhibiting HPIP oncoprotein.

A novel chemical inhibitor suppresses breast cancer cell growth and metastasis through inhibiting HPIP oncoprotein.

Journal: Cell death discovery

Published: May 06, 2021

MiR-4310 regulates hepatocellular carcinoma growth and metastasis through lipid synthesis.

MiR-4310 regulates hepatocellular carcinoma growth and metastasis through lipid synthesis.

Journal: Cancer letters

Published: May 05, 2021

miR-1224-3p Promotes Breast Cancer Cell Proliferation and Migration through PGM5-Mediated Aerobic Glycolysis.

miR-1224-3p Promotes Breast Cancer Cell Proliferation and Migration through PGM5-Mediated Aerobic Glycolysis.

Journal: Journal of oncology

Published: January 06, 2021

Showing 1-12 of 29

Last Updated: 09/26/2026